Il-1 Beta Reciprocally Regulates Chemokine And Insulin Secretion In Pancreatic Beta-Cells Via Nf-Kappa B

Proinflammatory cytokines impact islet beta-cell mass and function by altering the transcriptional activity within pancreatic beta-cells, producing increases in intracellular nitric oxide abundance and the synthesis and secretion of immunomodulatory proteins such as chemokines. Herein, we report that IL-1 beta, a major mediator of inflammatory responses associated with diabetes development, coordinately and reciprocally regulates chemokine and insulin secretion. We discovered that NF-kappa B controls the increase in chemokine transcription and secretion as well as the decrease in both insulin secretion and proliferation in response to IL-1 beta. Nitric oxide production, which is markedly elevated in pancreatic beta-cells exposed to IL-1 beta, is a negative regulator of both glucose-stimulated insulin secretion and glucose-induced increases in intracellular calcium levels. By contrast, the IL-1 beta-mediated production of the chemokines CCL2 and CCL20 was not influenced by either nitric oxide levels or glucose concentration. Instead, the synthesis and secretion of CCL2 and CCL20 in response to IL-1 beta were dependent on NF-kappa B transcriptional activity. We conclude that IL-1 beta-induced transcriptional reprogramming via NF-kappa B reciprocally regulates chemokine and insulin secretion while also negatively regulating beta-cell proliferation. These findings are consistent with NF-kappa B as a major regulatory node controlling inflammation-associated alterations in islet beta-cell function and mass.